Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Cellular Oncology
Published in: Cellular Oncology 5/2016

01-10-2016 | Original Paper

Nitric oxide increases the migratory activity of non-small cell lung cancer cells via AKT-mediated integrin αv and β1 upregulation

Authors: Vhudhipong Saisongkorh, Arnatchai Maiuthed, Pithi Chanvorachote

Published in: Cellular Oncology | Issue 5/2016

Login to get access

Abstract

Background

Previously, nitric oxide (NO) has been found to affect the metastatic behavior of various types of cancer. In addition, it has been found that alterations in integrin expression may have profound effects on cancer cell survival and migration. Here, we aimed at assessing the effects of non-toxic concentrations of NO on human non-small cell lung cancer (NSCLC) cells, including the expression of integrins and the migration of these cells.

Methods

The cytotoxic and proliferative effects of NO on human NSCLC-derived H460, H292 and H23 cells were tested by MTT assay. The migration capacities of these cells was evaluated by wound healing and transwell migration assays. The expression of integrins and migration-associated proteins was determined by Western blot analyses.

Results

We found that NO treatment caused a significant increase in the expression of integrin αv and β1 in all three NSCLC-derived cell lines tested. Known migration-associated proteins acting downstream of these integrins, including focal adhesion kinase (FAK), active RhoA (Rho-GTP) and active cell division control 42 (Cdc42-GTP), were found to be significantly activated in response to NO. In addition, we found that NO-treated cells showed an increased motility and that this motility was associated with a significant increase in the number of filopodia per cell. We also found that NO-treated cells exhibited increased active protein kinase G (PKG), protein kinase B (AKT) and FAK expression levels. Using a pharmacological approach, we found that the integrin-modulating effect of NO is most likely brought about by a PKG/AKT-dependent mechanism, since the observed changes in integrin expression were abolished by AKT inhibitors, but not by FAK inhibitors.

Conclusion

Our data suggest a novel role of NO in the regulation of integrin expression and, concomitantly, the migratory capacity of NSCLC cells.
Literature
1.
A. Khosravi, S. Shahrabi, M. Shahjahani, N. Saki, The bone marrow metastasis niche in retinoblastoma. Cell. Oncol. 38, 253–263 (2015)CrossRef
2.
J. A. Joyce, J. W. Pollard, Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239–252 (2009)CrossRefPubMed
3.
S. Wan, Y. Liu, Y. Weng, W. Wang, W. Ren, C. Fei, Y. Chen, Z. Zhang, T. Wang, J. Wang, BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells. Cell. Oncol. 37, 363–375 (2014)CrossRef
4.
A. Koren, E. Sodja, M. Rijavec, M. Jez, V. Kovac, P. Korosec, T. Cufer, Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients. Cell. Oncol. 38, 387–395 (2015)CrossRef
5.
E. Prodromaki, A. Korpetinou, E. Giannopoulou, E. Vlotinou, μ. Chatziathanasiadou, N. Papachristou, C. Scopa, H. Papadaki, H. Kalofonos, D. Papachristou, expression of the microRNA regulators Drosha, dicer and Ago2 in non-small cell lung carcinomas. Cell. Oncol. 38, 307–317 (2015)CrossRef
6.
C. Zeng, W. Fan, X. Zhang, RRM1 expression is associated with the outcome of gemcitabine-based treatment of non-small cell lung cancer patients–a short report. Cell. Oncol. 38, 319–325 (2015)CrossRef
7.
Z. B. Cincin, M. Unlu, B. Kiran, E. S. Bireller, Y. Baran, B. Cakmakoglu, Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells. Cell. Oncol. 38, 195–204 (2015)CrossRef
8.
9.
L. C. Jadeski, K. O. Hum, C. Chakraborty, P. K. Lala, Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int. J. Cancer 86, 30–39 (2000)CrossRefPubMed
10.
D. Fukumura, S. Kashiwagi, R. K. Jain, The role of nitric oxide in tumour progression. Nat. Rev. Cancer 6, 521–534 (2006)CrossRefPubMed
11.
C. Liu, C. Wang, T. Chen, H. Lin, C. Yu, H. Kuo, Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Brit. J. Cancer 78, 534 (1998)CrossRefPubMedPubMedCentral
12.
P. Chanvorachote, U. Nimmannit, Y. Lu, S. Talbott, B.-H. Jiang, Y. Rojanasakul, Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1. J. Biol. Chem. 284, 28476–28484 (2009)CrossRefPubMedPubMedCentral
13.
N. Yongsanguanchai, V. Pongrakhananon, A. Mutirangura, Y. Rojanasakul, P. Chanvorachote, Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells. Am. J. Physiol. - Cell Ph 308, C89–C100 (2015)CrossRef
14.
P. Chanvorachote, U. Nimmannit, C. Stehlik, L. Wang, B.-H. Jiang, B. Ongpipatanakul, Y. Rojanasakul, Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. Cancer Res. 66, 6353–6360 (2006)CrossRefPubMed
15.
X. Weiming, L. Z. Liu, M. Loizidou, M. Ahmed, I. G. Charles, The role of nitric oxide in cancer. Cell Res. 12, 311–320 (2002)CrossRef
16.
17.
S. P. Holly, M. K. Larson, L. V. Parise, Multiple roles of integrins in cell motility. Exp. Cell Res. 261, 69–74 (2000)CrossRefPubMed
18.
D. G. Stupack, D. A. Cheresh, Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 115, 3729–3738 (2002)CrossRefPubMed
19.
J. D. Hood, D. A. Cheresh, Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2, 91–100 (2002)CrossRefPubMed
20.
H. Truong, E. H. Danen, Integrin switching modulates adhesion dynamics and cell migration. Cell Adhes. Migr. 3, 179–181 (2009)CrossRef
21.
N. C. Wong, B. M. Mueller, C. F. Barbas, P. Ruminski, V. Quaranta, E. C. Lin, J. W. Smith, αv integrins mediate adhesion and migration of breast carcinoma cell lines. Clin. Exp. Metastasis 16, 50–61 (1998)CrossRefPubMed
22.
R. Hosotani, M. Kawaguchi, T. Masui, T. Koshiba, J. Ida, K. Fujimoto, M. Wada, R. Doi, M. Imamura, Expression of integrin αvβ3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. Pancreas 25, e30–e35 (2002)CrossRefPubMed
23.
P. T. Caswell, H. J. Spence, M. Parsons, D. P. White, K. Clark, K. W. Cheng, G. B. Mills, M. J. Humphries, A. J. Messent, K. I. Anderson, Rab25 associates with α5β1 integrin to promote invasive migration in 3D microenvironments. Dev. Cell 13, 496–510 (2007)CrossRefPubMed
24.
D. Wang, S. Müller, A. R. Amin, D. Huang, L. Su, Z. Hu, M. A. Rahman, S. Nannapaneni, L. Koenig, Z. Chen, The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma. Clin. Cancer Res. 18, 4589–4599 (2012)CrossRefPubMedPubMedCentral
25.
H. Guillou, A. Depraz-Depland, E. Planus, B. Vianay, J. Chaussy, A. Grichine, C. Albiges-Rizo, M. R. Block, Lamellipodia nucleation by filopodia depends on integrin occupancy and downstream Rac1 signaling. Exp. Cell Res. 314, 478–488 (2008)CrossRefPubMed
26.
27.
W. Guo, F. G. Giancotti, Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5, 816–826 (2004)CrossRefPubMed
28.
S. H. Francis, J. L. Busch, J. D. Corbin, cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev. 62, 525–563 (2010)CrossRefPubMedPubMedCentral
29.
S. H. Lee, J. S. Byun, P. J. Kong, H. J. Lee, D. K. Kim, H. S. Kim, J.-H. Sohn, J. J. Lee, S. Y. Lim, W. Chun, Inhibition of eNOS/sGC/PKG pathway decreases Akt phosphorylation induced by Kainic acid in mouse hippocampus. Korean J. Physiol. Pharmacol. 14, 37–43 (2010)CrossRefPubMedPubMedCentral
30.
D. J. Sieg, C. R. Hauck, D. Ilic, C. K. Klingbeil, E. Schaefer, C. H. Damsky, D. D. Schlaepfer, FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2, 249–256 (2000)CrossRefPubMed
31.
S. K. Mitra, D. D. Schlaepfer, Integrin-regulated FAK–Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18, 516–523 (2006)CrossRefPubMed
32.
M. S. Roberts, A. J. Woods, T. C. Dale, P. van der Sluijs, J. C. Norman, Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of αvβ3 and α5β1 integrins. Mol. Cell Biol. 24, 1505–1515 (2004)CrossRefPubMedPubMedCentral
33.
P. K. Lala, C. Chakraborty, Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2, 149–156 (2001)CrossRefPubMed
34.
P. Allavena, A. Sica, G. Solinas, C. Porta, A. Mantovani, The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 66, 1–9 (2008)CrossRefPubMed
35.
M. Valko, C. Rhodes, J. Moncol, M. Izakovic, M. Mazur, Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160, 1–40 (2006)CrossRefPubMed
36.
37.
P. Wongvaranon, V. Pongrakhananon, P. Chunhacha, P. Chanvorachote, Acquired resistance to chemotherapy in lung cancer cells mediated by prolonged nitric oxide exposure. Anticancer Res. 33, 5433–5444 (2013)PubMed
38.
P. Chanvorachote, U. Nimmannit, L. Wang, C. Stehlik, B. Lu, N. Azad, Y. Rojanasakul, Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein. J. Biol. Chem. 280, 42044–42050 (2005)CrossRefPubMed
39.
P. Chunhacha, P. Chanvorachote, Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. Int. J. Physiol. Pathophysiol. Pharmacol. 4, 149–155 (2012)PubMedPubMedCentral
40.
A. Maiuthed, P. Chanvorachote, Cisplatin at sub-toxic levels mediates integrin switch in lung cancer cells. Anticancer Res. 34, 7111–7117 (2014)PubMed
41.
42.
J. Luo, B. D. Manning, L. C. Cantley, Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4, 257–262 (2003)CrossRefPubMed
43.
J. Brognard, A. S. Clark, Y. Ni, P. A. Dennis, Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 61, 3986–3997 (2001)PubMed
44.
S. K. Mitra, D. A. Hanson, D. D. Schlaepfer, Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6, 56–68 (2005)CrossRefPubMed
Metadata
Title
Nitric oxide increases the migratory activity of non-small cell lung cancer cells via AKT-mediated integrin αv and β1 upregulation
Authors
Vhudhipong Saisongkorh
Arnatchai Maiuthed
Pithi Chanvorachote
Publication date
01-10-2016
Publisher
Springer Netherlands
Published in
Cellular Oncology / Issue 5/2016
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-016-0287-3

Other articles of this Issue 5/2016

Cellular Oncology 5/2016 Go to the issue

Report

A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report

Review

The role of lymphangiogenesis and angiogenesis in tumor metastasis

Original Paper

MGMT DNA repair gene promoter/enhancer haplotypes alter transcription factor binding and gene expression

Original Paper

Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells

Original Paper

Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma

Original Paper

Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits